Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.

Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S.

N Engl J Med. 1996 May 2;334(18):1150-5.

2.

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.

Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, Valanis B, Williams JH Jr.

J Natl Cancer Inst. 2004 Dec 1;96(23):1743-50.

3.

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.

Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Cherniack MG, Brodkin CA, Hammar S.

J Natl Cancer Inst. 1996 Nov 6;88(21):1550-9.

4.

The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.

Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack MG, Cullen MR, Glass A, et al.

Cancer Res. 1994 Apr 1;54(7 Suppl):2038s-2043s.

5.

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R.

N Engl J Med. 1996 May 2;334(18):1145-9.

6.

CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers.

Omenn GS, Goodman G, Grizzle J, Thornquist M, Rosenstock L, Barnhart S, Anderson G, Balmes J, Cherniack M, Cone J, et al.

Anticancer Drugs. 1991 Feb;2(1):79-86.

PMID:
1958856
7.

Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET).

Cartmel B, Dziura J, Cullen MR, Vegso S, Omenn GS, Goodman GE, Redlich CA.

Eur J Clin Nutr. 2005 Oct;59(10):1173-80.

PMID:
16015255
8.

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK.

J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70.

PMID:
8901854
9.

The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.

Goodman GE, Omenn GS, Thornquist MD, Lund B, Metch B, Gylys-Colwell I.

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):389-96.

10.

The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.

Omenn GS, Goodman GE, Thornquist MD, Rosenstock L, Barnhart S, Gylys-Colwell I, Metch B, Lund B.

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):381-7.

11.

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.

Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH.

J Natl Cancer Inst. 1999 Dec 15;91(24):2102-6.

PMID:
10601381
12.

Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study.

McLarty JW, Holiday DB, Girard WM, Yanagihara RH, Kummet TD, Greenberg SD.

Am J Clin Nutr. 1995 Dec;62(6 Suppl):1431S-1438S.

PMID:
7495244
13.
14.

Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.

Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC.

Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):767-73.

15.
16.

Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study.

Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J, Albanes D.

Am J Epidemiol. 2002 Sep 15;156(6):536-47.

PMID:
12226001
17.

Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.

Omenn GS, Goodman G, Thornquist M, Barnhart S, Balmes J, Cherniack M, Cullen M, Glass A, Keogh J, Liu D, Meyskens F Jr, Perloff M, Valanis B, Williams J Jr.

IARC Sci Publ. 1996;(136):67-85. No abstract available.

PMID:
8791118
18.

Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial.

Aliyu OA, Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich CA, Brodkin CA, Barnhart S, Rosenstock L, Israel L, Goodman GE, Thornquist MD, Omenn GS.

Am J Epidemiol. 2005 Nov 1;162(9):868-78. Epub 2005 Sep 21.

PMID:
16177148
20.

The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland.

Blumberg J, Block G.

Nutr Rev. 1994 Jul;52(7):242-5.

PMID:
8090376

Supplemental Content

Support Center